AdaptHealth Corp. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 804.03 million compared to USD 756.5 million a year ago. Net loss was USD 454.08 million compared to net income of USD 16.12 million a year ago. Basic loss per share from continuing operations was USD 3.37 compared to basic earnings per share from continuing operations of USD 0.11 a year ago. Diluted loss per share from continuing operations was USD 3.43 compared to diluted earnings per share from continuing operations of USD 0.11 a year ago.
For the nine months, sales was USD 2,341.94 million compared to USD 2,190.31 million a year ago. Net loss was USD 424.39 million compared to net income of USD 71.9 million a year ago. Basic loss per share from continuing operations was USD 3.15 compared to basic earnings per share from continuing operations of USD 0.49 a year ago. Diluted loss per share from continuing operations was USD 3.37 compared to diluted earnings per share from continuing operations of USD 0.35 a year ago.